The co-expression of EpCAM+CD45+ hybrid cells has already been described in the ascites of ovarian cancer patients, which the authors associate with a maintenance of epithelial features and the gain of pro-migratory characteristics [27]. Here, PTPRC is linked to ovarian cancer.